Joseph K. Belanoff

2011

In 2011, Joseph K. Belanoff earned a total compensation of $3.5M as Chief Executive Officer and President at Corcept Therapeutics.

Compensation breakdown

Option Awards$3,057,026
Salary$467,084
Total$3,524,110

Belanoff received $3.1M in option awards, accounting for 87% of the total pay in 2011.

Belanoff also received $467.1K in salary.

Rankings

In 2011, Joseph K. Belanoff's compensation ranked 1,721st out of 10,747 executives tracked by ExecPay. In other words, Belanoff earned more than 84.0% of executives.

ClassificationRankingPercentile
All
1,721
out of 10,747
84th
Division
Manufacturing
625
out of 3,960
84th
Major group
Chemicals And Allied Products
137
out of 1,038
87th
Industry group
Drugs
76
out of 786
90th
Industry
Pharmaceutical Preparations
64
out of 571
89th
Source: SEC filing on April 7, 2014.

Belanoff's colleagues

We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2011.

2011

Robert Roe

Corcept Therapeutics

Secretary

2011

G Robb

Corcept Therapeutics

Chief Financial Officer

2011

Anne LeDoux

Corcept Therapeutics

Chief Accounting Officer

2011

Steven Lo

Corcept Therapeutics

Senior Vice President and Chief Commercialization Officer

News

In-depth

You may also like